Healthcare provider profile · identity verified

Jo Anne Gregory, MD

Allopathic & Osteopathic Physicians|Family Medicine · LAKE VILLAGE, AR · NPI 1346252681

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Jo Anne Gregory, MD received $117.26 in general payments during 2025 across 6 reported records.

Boehringer Ingelheim Pharmaceuticals, Inc. accounted for 32.2% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 5 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Jardiance, Ozempic.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 85 claims for Farxiga by this doctor in 2024.

AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 56 claims for Symbicort by this doctor in 2024.

Boehringer Ingelheim Pharmaceuticals, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 123636 records involving 49438 distinct recipient NPIs. Public Medicare Part D data also shows 280 claims for Jardiance by this doctor in 2024.

Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 192 claims for Ozempic by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$117.26

6 reported records · 5 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Boehringer Ingelheim Pharmaceuticals, Inc.	Unresolved — no canonical attribution shown	$37.73	32.2%	2	2025
AstraZeneca Pharmaceuticals LP	Unresolved — no canonical attribution shown	$31.12	26.5%	1	2025
Novo Nordisk Inc	Unresolved — no canonical attribution shown	$19.84	16.9%	1	2025
Exact Sciences Corporation	Unresolved — no canonical attribution shown	$14.83	12.7%	1	2025
Amgen Inc.	Unresolved — no canonical attribution shown	$13.74	11.7%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$117.26	6

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
JARDIANCE Normalized: jardiance	Drug	Boehringer Ingelheim Pharmaceuticals, Inc.	$37.73	2	2025
Source payment records 2025-03-10 · Boehringer Ingelheim Pharmaceuticals, Inc. · $24.15 · Open Payments source 2025-05-05 · Boehringer Ingelheim Pharmaceuticals, Inc. · $13.58 · Open Payments source
BREZTRI Normalized: breztri	Drug	AstraZeneca Pharmaceuticals LP	$31.12	1	2025
Source payment records 2025-03-06 · AstraZeneca Pharmaceuticals LP · $31.12 · Open Payments source
Ozempic Normalized: ozempic	Drug	Novo Nordisk Inc	$19.84	1	2025
Source payment records 2025-07-22 · Novo Nordisk Inc · $19.84 · Open Payments source
Cologuard Collection Kit Normalized: cologuard collection kit	Device	Exact Sciences Corporation	$14.83	1	2025
Source payment records 2025-01-22 · Exact Sciences Corporation · $14.83 · Open Payments source
EVENITY Normalized: evenity	Biological	Amgen Inc.	$13.74	1	2025
Source payment records 2025-03-19 · Amgen Inc. · $13.74 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
JARDIANCE jardiance	2025	Jardiance	2024	280	exact normalized	Medicare Part D
Ozempic ozempic	2025	Ozempic	2024	192	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	FARXIGA open payments reported associated product	CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362	Farxiga · 2024 Exact normalized brand match · 1 Part D row	85	23
AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference	2025	SYMBICORT open payments reported associated product	CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610	Symbicort · 2024 Exact normalized brand match · 1 Part D row	56	suppressed by CMS
Boehringer Ingelheim Pharmaceuticals, Inc. Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 123636 supporting records · 49438 recipient NPIs · example record 1221811583	Jardiance · 2024 Exact normalized brand match · 1 Part D row	280	47
Novo Nordisk Inc Exact reporting entity; no affiliate inference	2025	Ozempic open payments reported associated product	CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076	Ozempic · 2024 Exact normalized brand match · 1 Part D row	192	29

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	1459	172
Amlodipine Besylate	Amlodipine Besylate	1035	206
Atorvastatin Calcium	Atorvastatin Calcium	907	186
Alprazolam	Alprazolam	634	83
Gabapentin	Gabapentin	630	133
Potassium Chloride	Potassium Chloride	567	123
Pantoprazole Sodium	Pantoprazole Sodium	551	122
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	537	55
Furosemide	Furosemide	536	121
Omeprazole	Omeprazole	526	103
Metoprolol Succinate	Metoprolol Succinate	508	110
Albuterol Sulfate Hfa	Albuterol Sulfate	411	94
Metformin Hcl	Metformin Hcl	370	75
Losartan Potassium	Losartan Potassium	348	67
Rosuvastatin Calcium	Rosuvastatin Calcium	346	72
Simvastatin	Simvastatin	338	66
Meloxicam	Meloxicam	314	73
Hydrochlorothiazide	Hydrochlorothiazide	309	67
Levothyroxine Sodium	Levothyroxine Sodium	296	59
Jardiance	Empagliflozin	280	47
Metoprolol Tartrate	Metoprolol Tartrate	280	57
Allopurinol	Allopurinol	261	53
Tamsulosin Hcl	Tamsulosin Hcl	230	52
Clopidogrel	Clopidogrel Bisulfate	219	52
Atenolol	Atenolol	217	35
Fluticasone Propionate	Fluticasone Propionate	207	60
Lisinopril	Lisinopril	206	46
Ozempic	Semaglutide	192	29
Spironolactone	Spironolactone	192	49
Tizanidine Hcl	Tizanidine Hcl	189	36
Zolpidem Tartrate	Zolpidem Tartrate	189	29
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	187	39
Chlorthalidone	Chlorthalidone	183	30
Oxycodone Hcl	Oxycodone Hcl	174	18
Tramadol Hcl	Tramadol Hcl	174	36
Carvedilol	Carvedilol	168	37
Terazosin Hcl	Terazosin Hcl	165	25
Diclofenac Sodium	Diclofenac Sodium	150	43
Citalopram Hbr	Citalopram Hydrobromide	145	32
Eliquis	Apixaban	138	30
Donepezil Hcl	Donepezil Hcl	135	36
Fluoxetine Hcl	Fluoxetine Hcl	134	22
Ibuprofen	Ibuprofen	134	41
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	133	29
Montelukast Sodium	Montelukast Sodium	133	23
Nifedipine Er	Nifedipine	131	24
Glimepiride	Glimepiride	127	24
Baclofen	Baclofen	122	29
Metoclopramide Hcl	Metoclopramide Hcl	119	25
Famotidine	Famotidine	118	31
Sucralfate	Sucralfate	117	31
Mirtazapine	Mirtazapine	115	23
Lorazepam	Lorazepam	112	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	110	21
Meclizine Hcl	Meclizine Hcl	109	38
Pravastatin Sodium	Pravastatin Sodium	107	26
Entresto	Sacubitril/Valsartan	101	16
Pregabalin	Pregabalin	101	21
Sertraline Hcl	Sertraline Hcl	100	21
Clonidine Hcl	Clonidine Hcl	98	18
Esomeprazole Magnesium	Esomeprazole Magnesium	98	24
Linzess	Linaclotide	96	21
Promethazine Hcl	Promethazine Hcl	96	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	95	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	94	22
Nitroglycerin	Nitroglycerin	94	31
Temazepam	Temazepam	92	17
Ventolin Hfa	Albuterol Sulfate	91	28
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	87	18
Prednisone	Prednisone	86	46
Farxiga	Dapagliflozin Propanediol	85	23
Escitalopram Oxalate	Escitalopram Oxalate	84	12
Benazepril Hcl	Benazepril Hcl	82	15
Cyproheptadine Hcl	Cyproheptadine Hcl	81	14
Glipizide	Glipizide	81	13
Carisoprodol	Carisoprodol	80	13
Amitriptyline Hcl	Amitriptyline Hcl	77	14
Hydroxyzine Hcl	Hydroxyzine Hcl	74	14
Clonazepam	Clonazepam	73	11
Estradiol	Estradiol	72	22
Trazodone Hcl	Trazodone Hcl	72	19
Vitamin D2	Ergocalciferol (Vitamin D2)	72	17
Alendronate Sodium	Alendronate Sodium	70	16
Duloxetine Hcl	Duloxetine Hcl	69	18
Ondansetron Odt	Ondansetron	69	23
Ranolazine Er	Ranolazine	68	suppressed
Hydralazine Hcl	Hydralazine Hcl	66	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	66	16
Azithromycin	Azithromycin	62	53
Enalapril Maleate	Enalapril Maleate	62	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	61	26
Levetiracetam	Levetiracetam	61	11
Megestrol Acetate	Megestrol Acetate	61	23
Naproxen	Naproxen	61	13
Celecoxib	Celecoxib	59	15
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	58	14
Triamcinolone Acetonide	Triamcinolone Acetonide	58	20
Trulicity	Dulaglutide	58	suppressed
Symbicort	Budesonide/Formoterol Fumarate	56	suppressed
Ondansetron Hcl	Ondansetron Hcl	54	16
Myrbetriq	Mirabegron	52	suppressed
Amiodarone Hcl	Amiodarone Hcl	51	12
Xarelto	Rivaroxaban	51	suppressed
Cilostazol	Cilostazol	50	suppressed
Ropinirole Hcl	Ropinirole Hcl	50	12
Amoxicillin	Amoxicillin	49	34
Diazepam	Diazepam	48	suppressed
Tamoxifen Citrate	Tamoxifen Citrate	48	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	48	11
Azelastine Hcl	Azelastine Hcl	46	21
Ezetimibe	Ezetimibe	46	suppressed
Tresiba Flextouch U-200	Insulin Degludec	46	11
Fenofibrate	Fenofibrate Nanocrystallized	45	suppressed
Ibandronate Sodium	Ibandronate Sodium	45	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	45	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	44	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	44	13
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	44	15
Fluconazole	Fluconazole	44	27
Methocarbamol	Methocarbamol	43	13
Venlafaxine Hcl Er	Venlafaxine Hcl	41	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	39	suppressed
Bumetanide	Bumetanide	39	suppressed
Naloxone Hcl	Naloxone Hcl	39	23
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	38	suppressed
Olanzapine	Olanzapine	37	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	37	suppressed
Paroxetine Hcl	Paroxetine Hcl	37	suppressed
Ibu	Ibuprofen	35	13
Carbidopa-Levodopa	Carbidopa/Levodopa	34	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	34	suppressed
Lovastatin	Lovastatin	34	suppressed
Folic Acid	Folic Acid	33	suppressed
Labetalol Hcl	Labetalol Hcl	33	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	33	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	24
Diclofenac Sodium Er	Diclofenac Sodium	31	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	31	suppressed
Breo Ellipta	Fluticasone/Vilanterol	29	suppressed
Nabumetone	Nabumetone	29	suppressed
Finasteride	Finasteride	27	suppressed
Glipizide Er	Glipizide	27	suppressed
Torsemide	Torsemide	27	suppressed
Terbinafine Hcl	Terbinafine Hcl	26	suppressed
Dexlansoprazole Dr	Dexlansoprazole	25	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	25	suppressed
Oxcarbazepine	Oxcarbazepine	25	suppressed
Synthroid	Levothyroxine Sodium	25	suppressed
Topiramate	Topiramate	25	suppressed
Arnuity Ellipta	Fluticasone Furoate	24	suppressed
Betamethasone Valerate	Betamethasone Valerate	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	23	suppressed
Tresiba Flextouch U-100	Insulin Degludec	23	suppressed
Anastrozole	Anastrozole	22	suppressed
Carbamazepine	Carbamazepine	22	suppressed
Klor-Con M20	Potassium Chloride	22	suppressed
Colchicine	Colchicine	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	18
Gemfibrozil	Gemfibrozil	20	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	19	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	19	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	19	suppressed
Warfarin Sodium	Warfarin Sodium	19	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	18	suppressed
Clonidine	Clonidine	17	suppressed
Digoxin	Digoxin	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	17	suppressed
Morphine Sulfate Er	Morphine Sulfate	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	14	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	14	suppressed
Levofloxacin	Levofloxacin	14	13
Nystatin	Nystatin	14	suppressed
Trimethoprim	Trimethoprim	14	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	13	suppressed
Calcitriol	Calcitriol	13	suppressed
Dexilant	Dexlansoprazole	13	suppressed
Famciclovir	Famciclovir	13	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Levemir	Insulin Detemir	13	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Prasugrel Hcl	Prasugrel Hcl	13	suppressed
Raloxifene Hcl	Raloxifene Hcl	13	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Minoxidil	Minoxidil	12	suppressed
Niacin Er	Niacin	12	suppressed
Novolin R	Insulin Regular, Human	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed
Theophylline Er	Theophylline Anhydrous	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$117.26 · 6 records	Boehringer Ingelheim Pharmaceuticals, Inc.	BREZTRI, Cologuard Collection Kit, EVENITY, JARDIANCE, Ozempic	4	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Jardiance play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error